Justine V. Cohen - Concepedia

Author

Justine V. Cohen

Also Known As

Brastianos, Priscilla K., J. COHEN, J. Cohen, J. V. Cohen, J.V. Cohen, JUSTINE V. COHEN, Justine Cohen, Justine V Cohen, Justine V. Cohen, Justine Vanessa Cohen

242

Publications

11.7K

Citations

H-Index

109

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Dana-Farber Cancer Institute Memorial Sloan Kettering Cancer Center Vanderbilt University Medical Center

About

Justine V. Cohen is an author at Massachusetts General Hospital specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	4.8K
2	Health Sciences	6	6	456
3	Cell Biology	2	2	202
4	Education	1	1	28
5	Allied Health Professions	1	1	28

Justine V. Cohen

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors Syed Mahmood, Michael G. Fradley, Justine V. Cohen, Journal of the American College of Cardiology Heart FailureAutoimmune DiseaseImmune Checkpoint InhibitorsImmunologyImmune Checkpoint Inhibitor	2018	1.5K
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial Sarah B. Goldberg, Scott Gettinger, Amit Mahajan, The Lancet Oncology Neuro-oncologyNon-small-cell Lung CancerUntreated Brain MetastasesMedicineEarly Analysis	2016	987
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer Erin M. Bange, Nicholas Han, Paul Wileyto, Nature Medicine	2021	503
High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma Alexander T. Faje, Donald P. Lawrence, Keith T. Flaherty, Cancer	2018	470
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis Lili Zhang, Magid Awadalla, Syed Mahmood, European Heart Journal	2020	328
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial Harriet M. Kluger, Veronica Chiang, Amit Mahajan, Journal of Clinical Oncology	2018	275
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis Magid Awadalla, Syed Mahmood, John D. Groarke, Journal of the American College of Cardiology InflammationHeart FailureAutoimmune DiseaseImmunodeficienciesMyocardial Infarction	2020	272
Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells Carole L. Berger, Robert E. Tigelaar, Justine V. Cohen, Blood	2004	243
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Divyanshu Dubey, William S. David, Kerry L. Reynolds, Annals of Neurology Timely ManagementDisease ProgressionSevere Neurological ToxicityImmunodeficienciesImmunology	2020	229
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors Amanda C. Guidon, Leeann B Burton, Bart K. Chwalisz, Journal for ImmunoTherapy of Cancer ImmunodeficienciesImmunologyPathologyConsensus Disease DefinitionsImmunotherapy	2021	197

Page 1